Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX

• Main Authors: Jing Li (Author), Jingtao Li (Author), Na Lyu (Author), Yue Ma (Author), Fei Liu (Author), Yuqing Feng (Author), Li Yao (Author), Zhiyong Hou (Author), Xiaofeng Song (Author), Hongchuan Zhao (Author), Xiaoya Li (Author), Yingdian Wang (Author), Cheng Xiao (Author), Baoli Zhu (Author)
• Format: Book
• Published: SAGE Publishing, 2020-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: FOLFOX treatment is a method used widely to reduce tumor size in low-set rectal cancer, with variable clinical results. FOLFOX agents comprise a mixture of oxaliplatin and 5-fluorouracil, the efficacy of which might be modulated by the gut microbiome in humans. This study aimed to determ...